Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 24101-24150 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06199908
AMT-562 in Patients With Selected Advanced Solid Tumors
PHASE1
Recruiting
72 participants
Started: May 20, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT06528379
Physical Activity Component of the Greek Interventional Geriatric Study to Prevent Cognitive Impairment and Disability (GINGER)
NA
Recruiting
200 participants
Started: May 20, 2024 · Completed: Sep 30, 2026
1 condition
3 sponsors
2 locations
NCT06528704
The Impact of Real Time Ventilation Feedback on Ventilation Rate and Tidal Volume During Cardiac Arrest.
NA
Recruiting
100 participants
Started: May 20, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT06389344
Effect of Esketamine on Conscious State in Patients With pDoC
NA
Recruiting
116 participants
Started: May 20, 2024 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT06070636
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
NA
Recruiting
30 participants
Started: May 20, 2024 · Completed: Jun 30, 2025
5 conditions
1 sponsor
1 location
NCT06616714
Faesiblity and Safety of Endoscopic sLeeve gastrOplasty in Patients With obEsity and nflammatoRy Bowel Disease
N/A
Recruiting
20 participants
Started: May 20, 2024 · Completed: May 20, 2027
2 conditions
1 sponsor
1 location
NCT06288659
aSAH Treatment Based on Intraventricular ICP Monitoring: A Prospective, Multicenter, Randomized and Controlled Trial
NA
Recruiting
372 participants
Started: May 20, 2024 · Completed: Dec 30, 2026
2 conditions
1 sponsor
1 location
NCT06132334
The Effects of Upper Extremity Aerobic Exercise Training in Patients With Type 2 Diabetes
NA
Recruiting
40 participants
Started: May 20, 2024 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT06824883
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
PHASE2
Recruiting
49 participants
Started: May 20, 2024 · Completed: May 20, 2027
1 condition
1 sponsor
1 location
NCT06061276
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
NA
Recruiting
40 participants
Started: May 20, 2024 · Completed: Dec 30, 2025
5 conditions
1 sponsor
1 location
NCT05647044
Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury
PHASE1
Recruiting
55 participants
Started: May 20, 2024 · Completed: Mar 31, 2028
3 conditions
1 sponsor
1 location
NCT06447727
Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM
N/A
Recruiting
30 participants
Started: May 20, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06865261
Effects of L-ARGinine and Liposomal Vitamin C Supplementation On Physical Performance
NA
Recruiting
100 participants
Started: May 20, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06458985
Disclosure Intervention for People in Treatment for Opioid Use Disorder
NA
Recruiting
480 participants
Started: May 20, 2024 · Completed: Aug 31, 2028
1 condition
3 sponsors
1 location
NCT06207071
Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial
NA
Recruiting
152 participants
Started: May 20, 2024 · Completed: Dec 31, 2026
4 conditions
2 sponsors
1 location
NCT06411522
Clinical and Microbiological Comparison of 0.12% CHX and 0.05% CHX+0.05%CPC Mouthwashes in TPS Patients
NA
Recruiting
72 participants
Started: May 20, 2024 · Completed: Sep 30, 2025
4 conditions
1 sponsor
1 location
NCT06158152
A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome.
NA
Recruiting
48 participants
Started: May 20, 2024 · Completed: Mar 1, 2026
1 condition
1 sponsor
2 locations
NCT06463275
SpinChip Hs-cTnI Determination of the 99th Percentile URL
N/A
Recruiting
1,600 participants
Started: May 20, 2024 · Completed: Aug 30, 2025
1 condition
3 sponsors
2 locations
NCT06635291
Improving the Diagnostic Accuracy of Children with DoC (IDeAl DesiRE)
N/A
Recruiting
113 participants
Started: May 20, 2024 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06307665
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
PHASE3
Recruiting
440 participants
Started: May 20, 2024 · Completed: Oct 13, 2027
1 condition
2 sponsors
124 locations
NCT06432517
Sources and Mechanisms of Energy Compensation
NA
Recruiting
81 participants
Started: May 20, 2024 · Completed: Dec 30, 2025
4 conditions
1 sponsor
1 location
NCT04886284
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
PHASE2
Recruiting
60 participants
Started: May 20, 2024 · Completed: Jul 31, 2026
4 conditions
1 sponsor
5 locations
NCT06353386
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
PHASE1/PHASE2
Recruiting
220 participants
Started: May 20, 2024 · Completed: Mar 31, 2028
1 condition
2 sponsors
77 locations
NCT06426953
Predictive Effect of TGF-β and INS-PI3K-AKT Related Proteins for POD in Diabetes Patients
N/A
Recruiting
180 participants
Started: May 20, 2024 · Completed: Aug 30, 2026
2 conditions
1 sponsor
2 locations
NCT07116408
Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage
PHASE4
Recruiting
20 participants
Started: May 20, 2024 · Completed: May 31, 2027
2 conditions
1 sponsor
1 location
NCT06364280
Pediatric Prehospital Airway Resuscitation Trial
NA
Recruiting
3,000 participants
Started: May 20, 2024 · Completed: Sep 30, 2029
5 conditions
3 sponsors
10 locations
NCT06461234
Pelvic Floor Rehabilitation of Female Pelvic Floor Dysfunction
N/A
Recruiting
1,360 participants
Started: May 20, 2024 · Completed: Nov 30, 2026
2 conditions
7 sponsors
1 location
NCT06403501
Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
PHASE3
Recruiting
692 participants
Started: May 20, 2024 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT06237452
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
PHASE3
Recruiting
852 participants
Started: May 20, 2024 · Completed: Oct 31, 2027
10 conditions
1 sponsor
197 locations
NCT06462378
Proton Therapy for Locally Advanced Cervical Cancer
PHASE2
Recruiting
55 participants
Started: May 20, 2024 · Completed: May 20, 2034
3 conditions
2 sponsors
1 location
NCT06222086
The Effects of Calisthenic Exercise Training in Patients With Type 2 Diabetes
NA
Recruiting
40 participants
Started: May 20, 2024 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06050135
Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer
NA
Recruiting
256 participants
Started: May 20, 2024 · Completed: Jul 31, 2028
2 conditions
3 sponsors
1 location
NCT06380049
Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data
N/A
Recruiting
90 participants
Started: May 20, 2024 · Completed: Apr 28, 2026
2 conditions
2 sponsors
1 location
NCT06444568
Modified Ketogenic Diet in Amnestic Mild Cognitive Impairments
NA
Recruiting
36 participants
Started: May 20, 2024 · Completed: Mar 1, 2025
2 conditions
2 sponsors
1 location
NCT06355037
Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
PHASE2
Recruiting
10 participants
Started: May 20, 2024 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT06456476
Patients With Obstructive Jaundice In Sohag University Hospital
N/A
Recruiting
130 participants
Started: May 20, 2024 · Completed: Nov 20, 2024
1 condition
1 sponsor
1 location
NCT06157892
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
PHASE2
Recruiting
172 participants
Started: May 20, 2024 · Completed: Jul 28, 2029
10 conditions
2 sponsors
125 locations
NCT06285890
Phase I Study of HC-7366 for Acute Myeloid Leukemia
PHASE1
Recruiting
18 participants
Started: May 20, 2024 · Completed: Dec 31, 2029
1 condition
2 sponsors
1 location
NCT06118840
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA
Recruiting
6,450 participants
Started: May 20, 2024 · Completed: Dec 31, 2026
4 conditions
1 sponsor
21 locations
NCT06273904
Modulating Escape Using Focused Ultrasound
NA
Recruiting
40 participants
Started: May 20, 2024 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT05875805
A Telehealth Advance Care Planning Intervention
NA
Recruiting
207 participants
Started: May 20, 2024 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT06472102
Cardioneuroablation: Fragmented Atrial Potentials, Intracardiac Echocardiography and Computed Tomography
NA
Recruiting
100 participants
Started: May 20, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06420752
Passive Stretching in Peripheral Arterial Disease Patients
PHASE2
Recruiting
64 participants
Started: May 20, 2024 · Completed: Dec 31, 2029
3 conditions
1 sponsor
1 location
NCT05996120
Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)
NA
Recruiting
100 participants
Started: May 20, 2024 · Completed: Feb 28, 2026
4 conditions
10 sponsors
11 locations
NCT06015880
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
PHASE1
Recruiting
30 participants
Started: May 20, 2024 · Completed: Jun 29, 2026
3 conditions
1 sponsor
7 locations
NCT06650436
DEliriuM in STroke: the Link Between Stroke, Delirium and Long-term Cognitive Impairment
N/A
Recruiting
150 participants
Started: May 20, 2024 · Completed: May 31, 2026
3 conditions
3 sponsors
1 location
NCT06538714
Interval Training and Cardio-metabolic Health in Overweight/Obese Girls
NA
Recruiting
45 participants
Started: May 20, 2024 · Completed: Aug 19, 2024
4 conditions
1 sponsor
2 locations
NCT06531707
Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine
PHASE3
Recruiting
177 participants
Started: May 20, 2024 · Completed: Feb 20, 2025
1 condition
1 sponsor
1 location
NCT06635330
Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
PHASE1/PHASE2
Recruiting
5 participants
Started: May 20, 2024 · Completed: Sep 22, 2027
1 condition
1 sponsor
1 location
NCT06542211
Observation on the Efficacy of Improving Ankle Dorsiflexion Limitation in Patients With Plantar Fasciitis
NA
Recruiting
40 participants
Started: May 20, 2024 · Completed: Mar 2, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
480
481
482
483
484
485
486
More pages
1333
Next